JILLIAN STERNER: Open Payments
NPI 1609422963 · NEWPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 69 payments from 21 companies in 2025. Trend: 2023 $1,007 · 2024 $1,067 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $269 |
| BridgeBio Pharma, Inc. | 2 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $126 |
| Esperion Therapeutics, Inc. | 6 | $120 |
| ABBVIE INC. | 5 | $112 |
| PFIZER INC. | 6 | $103 |
| Novo Nordisk Inc | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Amgen Inc. | 4 | $73 |
| Sonex Health, Inc. | 2 | $73 |
Products named: CAMZYOS, Attruby, JARDIANCE, NEXLETOL, ELIQUIS, VYNDAQEL, Kerendia, VRAYLAR.
Industry payments across PA — which companies pay providers there.
